Can a common gout pill ease pain from this rare joint disease?
NCT ID NCT06855433
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 4 times
Summary
This study tests whether colchicine, a drug used for gout, can lower inflammation and pain in people with CPPD disease. About 150 adults will take either colchicine or a placebo daily for 6 months. Researchers will measure blood markers and joint symptoms to see if the drug helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CPPD - CALCIUM PYROPHOSPHATE DEPOSITION DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston University Medical Center/Boston Medical Center
RECRUITINGBoston, Massachusetts, 02118, United States
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02118, United States
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
University of Alabama - Birmingham
RECRUITINGBirmingham, Alabama, 35233, United States
-
University of California - Los Angeles
RECRUITINGLos Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.